State of Wisconsin Investment Board
FDMT icon

State of Wisconsin Investment Board’s 4D Molecular Therapeutics FDMT Stock Holding History

State of Wisconsin Investment Board’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Buy
56,252
+33,296
+145% +$324K ﹤0.01% 1914
2026
Q1 		$214K Buy
+22,956
New +$200K ﹤0.01% 2336
2025
Q3 		– Sell
-19,798
Closed -$73.5K – 2429
2025
Q2 		$73.5K Sell
19,798
-6,538
-25% -$23K ﹤0.01% 2287
2025
Q1 		$85.1K Sell
26,336
-33,412
-56% -$157K ﹤0.01% 2185
2024
Q4 		$333K Sell
59,748
-4,385
-7% -$34.4K ﹤0.01% 1975
2024
Q3 		$693K Buy
64,133
+4,604
+8% +$76.4K ﹤0.01% 1712
2024
Q2 		$1.25M Buy
59,529
+33,389
+128% +$838K ﹤0.01% 1485
2024
Q1 		$833K Sell
26,140
-17,144
-40% -$437K ﹤0.01% 1485
2023
Q4 		$877K Sell
43,284
-8,897
-17% -$117K ﹤0.01% 1430
2023
Q3 		$664K Buy
52,181
+17,116
+49% +$286K ﹤0.01% 1569
2023
Q2 		$634K Buy
35,065
+18,605
+113% +$343K ﹤0.01% 1703
2023
Q1 		$283K Buy
16,460
+3,160
+24% +$61.4K ﹤0.01% 2129
2022
Q4 		$295K Sell
13,300
-41,436
-76% -$640K ﹤0.01% 2103
2022
Q3 		$440K Buy
54,736
+28,025
+105% +$254K ﹤0.01% 2034
2022
Q2 		$186K Sell
26,711
-10,489
-28% -$102K ﹤0.01% 2513
2022
Q1 		$562K Buy
37,200
+5,100
+16% +$80.1K ﹤0.01% 1770
2021
Q4 		$704K Buy
32,100
+19,300
+151% +$473K ﹤0.01% 1560
2021
Q3 		$345K Buy
12,800
+4,014
+46% +$114K ﹤0.01% 1837
2021
Q2 		$212K Buy
+8,786
New +$269K ﹤0.01% 2029

Other funds holding FDMT

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM

State of Wisconsin Investment Board's FDMT Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its 4D Molecular Therapeutics (FDMT) stake by 145% in Q2 2026, buying an estimated $324K and bringing the position to 56,252 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

State of Wisconsin Investment Board first reported a position in FDMT in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.25M in Q2 2024. 158 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • State of Wisconsin Investment Board held 56,252 shares of 4D Molecular Therapeutics worth $748K as of Q2 2026.
  • State of Wisconsin Investment Board bought 33,296 4D Molecular Therapeutics shares in Q2 2026, an estimated $324K.
  • 4D Molecular Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1914 holding.
  • State of Wisconsin Investment Board first reported a position in 4D Molecular Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • State of Wisconsin Investment Board's 4D Molecular Therapeutics position peaked at $1.25M in Q2 2024.
  • 158 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.